A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

NCT03775434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Eczema
Atopic Dermatitis

Interventions

DRUG: Experimental: B244

Sponsor

AOBiome LLC

Collaborators

[object Object]